30Mar
Covid–19 coronavirus: Global merger review update
Merger review processes are being impacted worldwide as merger control authorities adapt to take account of the consequences of Covid-19 coronavirus. While critical transactions are likely to be reviewed, as far as possible, in accordance with normal...
By:
Allen & Overy LLP
Related
Across the public hospital sector, M&A activity has increased significantly over the past decade. Gi...
Read More >
Many provisions of the SECURE Act passed at the end of last year will change the way qualified plans...
Read More >
The peak H-2B filing season opened on January 2, 2020, and by the next day the Office of Foreign Lab...
Read More >
Seyfarth Synopsis: The Court of Appeals for the Seventh Circuit recently held that once a multi-empl...
Read More >
While it’s true that acts of generosity sometimes backfire on those who offer them, the Court’s ru...
Read More >
Despite the changes and uncertainty rippling across the entire venture-backed startup ecosystem, the...
Read More >